Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

YTEN - Yield10 Bioscience

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Dan Thunderbolt, Apr 19, 2018.

  1. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
    Bought some shares of YTEN the last couple of days. YTEN is good for a nice run from time to time. The licensing deal with Monsanto gave them tremendous credibility.

    Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean
    Dec 11, 2017
    http://ir.yield10bio.com/news-relea...grants-research-license-monsanto-evaluate-two

    Market Cap of YTEN is currently around $17 million. The company ended 2017 with cash on the balance sheet of $14.5 million. The Company anticipates that its current cash resources will be sufficient to fund operations and meet its obligations for at least the next twelve months. This should be sufficient time to deliver some good news to boost the stock price imo.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    6,129
    Likes Received:
    1,449
    [​IMG]
    Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States. It is developing various yield traits using proprietary advanced biotechnology trait gene discovery platforms. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
     
    OldFart likes this.
  3. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  4. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  5. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  6. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
    Nice end of day trading action. Keep on radar for possible spike in share price. YTEN makes a run from time to time.
     
  7. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  8. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  9. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
    Yield10 Bioscience's (YTEN) CEO Oli Peoples on Q1 2018 Results - Earnings Call Transcript
    May.10.18
    https://seekingalpha.com/article/41...ples-q1-2018-results-earnings-call-transcript

    "We ended first quarter of 2018 with $11.6 million in cash, cash equivalents and short-term securities on the balance sheet."

    "We expect our cash on hand together with revenue expected under current government grants to support our operations to a number of technology proof points into mid-2019."

    "Monsanto is the world leader in developing biotech traits in soybean. So it’s great to have them working in C3003 with a unique capabilities and capacity. Our new business model for working with ag major, its also attracted the interest of other parties for both additional gene traits as well as other crops. We have some discussions ongoing and our goal is to work with additional ag companies to bring forward new yield traits."
     
  10. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  11. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
    SeeThruEquity Issues Update on Yield10 Bioscience, Inc.

    May 23, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Yield10 Bioscience, Inc. (NASDAQ: YTEN).

    https://www.accesswire.com/500588/SeeThruEquity-Issues-Update-on-Yield10-Bioscience-Inc

    No change to price target at this time ($8.50)
    Our price target for YTEN is unchanged at this time. 1Q18 results set the stage for an important planting season, which should provide additional data for the company's portfolio of traits. We plan to re-evaluate the price target following results, a more expansive update of the Monsanto relationship, or more visibility into the company's other partnership discussions.
     
  12. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
    OldFart likes this.
  13. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2
  14. Dan Thunderbolt

    Joined:
    Aug 26, 2017
    Messages:
    112
    Likes Received:
    2

Share This Page